CVS Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
105.5B
+5.6%
99.9B
-5.0%
105.1B
+2.8%
102.2B
+3.9%
98.4B
Cost of Revenue
90.3B
+6.5%
84.8B
-7.9%
92.1B
+3.4%
89.1B
+4.4%
85.3B
Gross Profit
15.1B
+0.4%
15.1B
+16.0%
13.0B
-1.5%
13.2B
+0.5%
13.1B
Operating Expenses
11.0B
+0.9%
10.9B
-4.5%
11.5B
-32.7%
17.0B
+51.7%
11.2B
R&D
0
0
0
0
0
SG&A
0
0
0
0
0
Operating Income
4.1B
-1.1%
4.1B
+170.5%
1.5B
+139.5%
-3839000000
-302.7%
1.9B
EBITDA
5.2B
-0.6%
5.2B
+95.9%
2.7B
-11.8%
3.0B
-1.5%
3.1B
Net Income
3.0B
+1.3%
3.0B
+1.2%
2.9B
+173.3%
-3990000000
-493.9%
1.0B
EPS (Basic)
$2.33
+0.9%
$2.31
+0.0%
$2.31
+173.8%
$-3.13
-486.4%
$0.81
EPS (Diluted)
$2.31
+0.4%
$2.30
+0.0%
$2.30
+173.5%
$-3.13
-491.2%
$0.80
Shares (Diluted)
1.3B
+0.6%
1.3B
-0.2%
1.3B
+0.9%
1.3B
-0.1%
1.3B
CVS HEALTH (CVS) โ€” Financials